Way undervalued. It should be trading at 3-4x current year revenue IMO. It's trading at about 1.5x ($18m market cap with our current SP) our current year revenue if we do $10-15m this year.
That's plain ridiculous considering other companies that trade at $50m + market caps I see. Just a matter of time IMO and I expect a gradual climb to around 30-40 cents as next one to two quarters hit. If Novalere deal is announced, we could go to double that fast.
News 
Market Data 
Discover 
